![Xiao Run Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Run Chang
Directeur/Membre du Conseil chez Beijing Hongcheng Liye Technology Co., Ltd.
Postes actifs de Xiao Run Chang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Beijing Hongcheng Liye Technology Co., Ltd.
![]() Beijing Hongcheng Liye Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Hongcheng Liye Technology Co., Ltd. provides integrated services including technology platform development, operation, and maintenance. Its services include online higher education, off-campus learning center, adult education, information technology training, and corporate training. The company was founded on May 19, 2003 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 18/12/2016 | - |
Independent Dir/Board Member | 18/12/2016 | - | |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Directeur/Membre du Conseil | 01/09/2015 | - |
Independent Dir/Board Member | 01/09/2015 | - | |
Guodu Securities Co., Ltd.
![]() Guodu Securities Co., Ltd. Investment Banks/BrokersFinance Guodu Securities Co., Ltd. engages in the provision of capital market services. It offers securities brokerage, securities investment consulting, financial advisors related to trading and securities investment activities, securities underwriting and sponsorship, securities proprietary trading, securities asset management and securities investment fund agency sales. The firm also involves in the intermediary introduction business for future companies; margin financing and securities lending business; agency sales of financial products business; and public offering of securities investment fund management business. The company was founded on December 28, 2001 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 25/12/2020 | - |
Independent Dir/Board Member | 25/12/2020 | - |
Historique de carrière de Xiao Run Chang
Anciens postes connus de Xiao Run Chang
Sociétés | Poste | Début | Fin |
---|---|---|---|
WESTERN SECURITIES CO.,LTD. | Directeur/Membre du Conseil | 01/11/2014 | - |
Independent Dir/Board Member | 01/11/2014 | - |
Formation de Xiao Run Chang
Renmin University of China | Doctorate Degree |
Statistiques
Internationale
Chine | 6 |
Opérationnelle
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Doctorate Degree | 1 |
Sectorielle
Finance | 3 |
Technology Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
WESTERN SECURITIES CO.,LTD. | Finance |
![]() | Finance |
Entreprise privées | 2 |
---|---|
Beijing Hongcheng Liye Technology Co., Ltd.
![]() Beijing Hongcheng Liye Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Hongcheng Liye Technology Co., Ltd. provides integrated services including technology platform development, operation, and maintenance. Its services include online higher education, off-campus learning center, adult education, information technology training, and corporate training. The company was founded on May 19, 2003 and is headquartered in Beijing, China. | Technology Services |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Bourse
- Insiders
- Xiao Run Chang
- Expérience